Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1950758744;58745;58746 chr2:178593781;178593780;178593779chr2:179458508;179458507;179458506
N2AB1786653821;53822;53823 chr2:178593781;178593780;178593779chr2:179458508;179458507;179458506
N2A1693951040;51041;51042 chr2:178593781;178593780;178593779chr2:179458508;179458507;179458506
N2B1044231549;31550;31551 chr2:178593781;178593780;178593779chr2:179458508;179458507;179458506
Novex-11056731924;31925;31926 chr2:178593781;178593780;178593779chr2:179458508;179458507;179458506
Novex-21063432125;32126;32127 chr2:178593781;178593780;178593779chr2:179458508;179458507;179458506
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAT
  • RefSeq wild type template codon: CTA
  • Domain: Fn3-29
  • Domain position: 29
  • Structural Position: 30
  • Q(SASA): 0.2378
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/V rs1177368382 0.205 0.989 N 0.696 0.485 0.515882253919 gnomAD-2.1.1 4.04E-06 None None None None I None 0 0 None 0 0 None 0 None 0 8.93E-06 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.7854 likely_pathogenic 0.7989 pathogenic -0.281 Destabilizing 0.978 D 0.599 neutral N 0.492564139 None None I
D/C 0.9419 likely_pathogenic 0.949 pathogenic 0.212 Stabilizing 0.999 D 0.696 prob.neutral None None None None I
D/E 0.7761 likely_pathogenic 0.8064 pathogenic -0.525 Destabilizing 0.928 D 0.407 neutral N 0.489246003 None None I
D/F 0.9661 likely_pathogenic 0.9696 pathogenic -0.541 Destabilizing 0.999 D 0.683 prob.neutral None None None None I
D/G 0.7728 likely_pathogenic 0.7635 pathogenic -0.506 Destabilizing 0.865 D 0.467 neutral N 0.506922639 None None I
D/H 0.8309 likely_pathogenic 0.8627 pathogenic -0.839 Destabilizing 0.994 D 0.677 prob.neutral N 0.509124685 None None I
D/I 0.9053 likely_pathogenic 0.9321 pathogenic 0.269 Stabilizing 0.992 D 0.699 prob.neutral None None None None I
D/K 0.8987 likely_pathogenic 0.9319 pathogenic 0.241 Stabilizing 0.968 D 0.563 neutral None None None None I
D/L 0.9233 likely_pathogenic 0.9299 pathogenic 0.269 Stabilizing 0.992 D 0.677 prob.neutral None None None None I
D/M 0.963 likely_pathogenic 0.9635 pathogenic 0.702 Stabilizing 0.999 D 0.676 prob.neutral None None None None I
D/N 0.2498 likely_benign 0.2214 benign -0.007 Destabilizing 0.039 N 0.204 neutral N 0.472409196 None None I
D/P 0.974 likely_pathogenic 0.9768 pathogenic 0.109 Stabilizing 0.992 D 0.695 prob.neutral None None None None I
D/Q 0.9081 likely_pathogenic 0.9294 pathogenic 0.026 Stabilizing 0.983 D 0.676 prob.neutral None None None None I
D/R 0.9076 likely_pathogenic 0.9327 pathogenic 0.121 Stabilizing 0.983 D 0.695 prob.neutral None None None None I
D/S 0.4538 ambiguous 0.4361 ambiguous -0.131 Destabilizing 0.895 D 0.475 neutral None None None None I
D/T 0.6446 likely_pathogenic 0.6116 pathogenic 0.05 Stabilizing 0.983 D 0.544 neutral None None None None I
D/V 0.8229 likely_pathogenic 0.8554 pathogenic 0.109 Stabilizing 0.989 D 0.696 prob.neutral N 0.505655191 None None I
D/W 0.9922 likely_pathogenic 0.9933 pathogenic -0.524 Destabilizing 0.999 D 0.701 prob.neutral None None None None I
D/Y 0.7643 likely_pathogenic 0.8086 pathogenic -0.326 Destabilizing 0.999 D 0.683 prob.neutral D 0.536383199 None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.